A Pityrosporum Fungal Infection Following Infliximab Therapy in a Crohn's Disease Patient
Intestinal Research
; : 177-180, 2010.
Article
in En
| WPRIM
| ID: wpr-174476
Responsible library:
WPRO
ABSTRACT
Crohn's disease (CD) is a chronic immune-mediated inflammatory disorder. Treatment strategies for CD are targeted toward various components of the proinflammatory mediators and subsequent immune response. Recently, the anti-tumor necrosis factor (TNF) monoclonal antibody, infliximab has been used in patients with CD. However, uncommon and unusual infections have been reported during anti-TNF-alpha therapy and immunomodulator. Here, we report a case of pityriasis versicolor occurring in a patient with CD receiving infliximab treatment. The patient was successfully treated with topical ketoconazole.
Key words
Full text:
1
Database:
WPRIM
Main subject:
Tinea Versicolor
/
Crohn Disease
/
Infliximab
/
Ketoconazole
/
Malassezia
/
Antibodies, Monoclonal
/
Necrosis
Limits:
Humans
Language:
En
Journal:
Intestinal Research
Year:
2010
Document type:
Article